422 related articles for article (PubMed ID: 23850902)
1. Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension).
Chen SL; Zhang FF; Xu J; Xie DJ; Zhou L; Nguyen T; Stone GW
J Am Coll Cardiol; 2013 Sep; 62(12):1092-1100. PubMed ID: 23850902
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous pulmonary artery denervation completely abolishes experimental pulmonary arterial hypertension in vivo.
Chen SL; Zhang YJ; Zhou L; Xie DJ; Zhang FF; Jia HB; Wong SS; Kwan TW
EuroIntervention; 2013 Jun; 9(2):269-76. PubMed ID: 23466961
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic, functional, and clinical responses to pulmonary artery denervation in patients with pulmonary arterial hypertension of different causes: phase II results from the Pulmonary Artery Denervation-1 study.
Chen SL; Zhang H; Xie DJ; Zhang J; Zhou L; Rothman AM; Stone GW
Circ Cardiovasc Interv; 2015 Nov; 8(11):e002837. PubMed ID: 26553699
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary Artery Denervation Significantly Increases 6-Min Walk Distance for Patients With Combined Pre- and Post-Capillary Pulmonary Hypertension Associated With Left Heart Failure: The PADN-5 Study.
Zhang H; Zhang J; Chen M; Xie DJ; Kan J; Yu W; Li XB; Xu T; Gu Y; Dong J; Gu H; Han Y; Chen SL
JACC Cardiovasc Interv; 2019 Feb; 12(3):274-284. PubMed ID: 30732732
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary artery denervation improves pulmonary arterial hypertension induced right ventricular dysfunction by modulating the local renin-angiotensin-aldosterone system.
Liu C; Jiang XM; Zhang J; Li B; Li J; Xie DJ; Hu ZY
BMC Cardiovasc Disord; 2016 Oct; 16(1):192. PubMed ID: 27724864
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary Artery Denervation Attenuates Pulmonary Arterial Remodeling in Dogs With Pulmonary Arterial Hypertension Induced by Dehydrogenized Monocrotaline.
Zhou L; Zhang J; Jiang XM; Xie DJ; Wang JS; Li L; Li B; Wang ZM; Rothman AMK; Lawrie A; Chen SL
JACC Cardiovasc Interv; 2015 Dec; 8(15):2013-2023. PubMed ID: 26738673
[TBL] [Abstract][Full Text] [Related]
7. Sympathetic innervation of canine pulmonary artery and morphometric and functional analysis in dehydromonocrotaline-induced models after pulmonary artery denervation.
Jiang X; Zhang J; Zhou L; Luo J; Wang J; Li L; Chen S
Interact Cardiovasc Thorac Surg; 2020 Nov; 31(5):708-717. PubMed ID: 33057705
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary Artery Denervation for Patients With Residual Pulmonary Hypertension After Pulmonary Endarterectomy.
Romanov A; Cherniavskiy A; Novikova N; Edemskiy A; Ponomarev D; Shabanov V; Losik D; Elesin D; Stenin I; Mikheenko I; Zhizhov R; Kretov E; Pokushalov E; Po SS; Martynyuk TV; Steinberg JS
J Am Coll Cardiol; 2020 Aug; 76(8):916-926. PubMed ID: 32819465
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary Artery Denervation: Update on Clinical Studies.
Zhang H; Chen SL
Curr Cardiol Rep; 2019 Sep; 21(10):124. PubMed ID: 31486924
[TBL] [Abstract][Full Text] [Related]
10. Utility of right ventricular Tei-index for assessing disease severity and determining response to treatment in patients with pulmonary arterial hypertension.
Ogihara Y; Yamada N; Dohi K; Matsuda A; Tsuji A; Ota S; Ishikura K; Nakamura M; Ito M
J Cardiol; 2014 Feb; 63(2):149-53. PubMed ID: 24012334
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomized PADN-CFDA Trial.
Zhang H; Wei Y; Zhang C; Yang Z; Kan J; Gu H; Fan F; Gu H; Wang Q; Xie D; Zhang G; Guo X; Yin Y; Jin B; Zhou H; Yang Z; Wang Z; Xin Y; Zhang C; Meng L; Wang X; Sun J; Zhao C; Zhang J; Yan X; Chen F; Yao C; Stone GW; Chen SL
JACC Cardiovasc Interv; 2022 Dec; 15(23):2412-2423. PubMed ID: 36121246
[TBL] [Abstract][Full Text] [Related]
12. Treatment effects of pulmonary artery denervation for pulmonary arterial hypertension stratified by REVEAL risk score: Results from PADN-CFDA trial.
Zhang J; Kan J; Wei Y; Zhang C; Yang Z; Gu H; Fan F; Gu H; Wang Q; Xie D; Zhang G; Guo X; Yin Y; Jin B; Zhou H; Yang Z; Wang Z; Xin Y; Zhang C; Meng L; Wang X; Zhao C; Zhang H; Yan X; Chen F; Yao C; Benza RL; Stone GW; Chen SL
J Heart Lung Transplant; 2023 Aug; 42(8):1140-1151. PubMed ID: 36990173
[TBL] [Abstract][Full Text] [Related]
13. Transcatheter radiofrequency pulmonary artery denervation in swine: the evaluation of lesion degree, hemodynamics and pulmonary hypertension inducibility.
Goncharova NS; Condori Leandro HI; Vakhrushev AD; Koshevaya EG; Skorik YA; Mitrofanova LB; Murashova LA; Korobchenko LE; Andreeva EM; Lebedev DS; Moiseeva OM; Mikhaylov EN
BMC Pulm Med; 2021 Dec; 21(1):418. PubMed ID: 34922518
[TBL] [Abstract][Full Text] [Related]
14. Meta-Analysis of Pulmonary Artery Denervation for Treatment of Pulmonary Hypertension.
Zuo W; Liu N; Xiao Y; Xie Y; Liu Q
Braz J Cardiovasc Surg; 2022 Aug; 37(4):554-565. PubMed ID: 35976208
[TBL] [Abstract][Full Text] [Related]
15. Effect of pulmonary artery denervation in postcapillary pulmonary hypertension: results of a randomized controlled translational study.
Garcia-Lunar I; Pereda D; Santiago E; Solanes N; Nuche J; Ascaso M; Bobí J; Sierra F; Dantas AP; Galán C; San Antonio R; Sánchez-Quintana D; Sánchez-González J; Barberá JA; Rigol M; Fuster V; Ibáñez B; Sabaté M; García-Álvarez A
Basic Res Cardiol; 2019 Jan; 114(2):5. PubMed ID: 30635778
[TBL] [Abstract][Full Text] [Related]
16. Utility of right ventricular Tei index in the noninvasive evaluation of chronic thromboembolic pulmonary hypertension before and after pulmonary thromboendarterectomy.
Blanchard DG; Malouf PJ; Gurudevan SV; Auger WR; Madani MM; Thistlethwaite P; Waltman TJ; Daniels LB; Raisinghani AB; DeMaria AN
JACC Cardiovasc Imaging; 2009 Feb; 2(2):143-9. PubMed ID: 19356547
[TBL] [Abstract][Full Text] [Related]
17. An Ovine Model for Percutaneous Pulmonary Artery Laser Denervation: Perivascular Innervation and Ablation Lesion Characteristics.
Condori Leandro HI; Koshevaya EG; Mitrofanova LB; Vakhrushev AD; Goncharova NS; Korobchenko LE; Andreeva EM; Lebedev DS; Mikhaylov EN
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445490
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary Artery Denervation as an Innovative Treatment for Pulmonary Hypertension With and Without Heart Failure.
Kim CW; Aronow WS; Dutta T; Spevack DM; Frishman WH
Cardiol Rev; 2021 Mar-Apr 01; 29(2):89-95. PubMed ID: 32032132
[TBL] [Abstract][Full Text] [Related]
19. Treatment goals of pulmonary hypertension.
McLaughlin VV; Gaine SP; Howard LS; Leuchte HH; Mathier MA; Mehta S; Palazzini M; Park MH; Tapson VF; Sitbon O
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D73-81. PubMed ID: 24355644
[TBL] [Abstract][Full Text] [Related]
20. 3-Year Outcome in Patients With Combined Precapillary and Postcapillary Pulmonary Hypertension: Results From PADN-5 Trial.
Zhang H; Kan J; Zhang J; Xie D; Li X; Zhou W; Dong J; Gu H; Han Y; Chen SL
JACC Heart Fail; 2023 Aug; 11(8 Pt 2):1135-1146. PubMed ID: 37354146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
